Microbiota in pancreatic health and disease: the next frontier in microbiome research

Nat Rev Gastroenterol Hepatol. 2020 Jan;17(1):53-64. doi: 10.1038/s41575-019-0242-7. Epub 2019 Dec 6.

Abstract

Diseases intrinsic to the pancreas such as pancreatitis, pancreatic cancer and type 1 diabetes mellitus impart substantial health and financial burdens on society but identification of novel mechanisms contributing to these pathologies are slow to emerge. A novel area of research suggests that pancreatic-specific disorders might be modulated by the gut microbiota, either through a local (direct pancreatic influence) or in a remote (nonpancreatic) fashion. In this Perspectives, we examine literature implicating microorganisms in diseases of the pancreas, specifically pancreatitis, type 1 diabetes mellitus and pancreatic ductal adenocarcinoma. We also discuss evidence of an inherent pancreatic microbiota and the influence of the intestinal microbiota as it relates to disease association and development. In doing so, we address pitfalls in the current literature and areas of investigation that are needed to advance a developing field of research that has clinical potential to reduce the societal burden of pancreatic diseases.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Bacterial Translocation
  • Carcinoma, Pancreatic Ductal / microbiology*
  • Diabetes Mellitus, Type 1 / immunology
  • Diabetes Mellitus, Type 1 / microbiology*
  • Gastrointestinal Microbiome / immunology
  • Gastrointestinal Microbiome / physiology*
  • Humans
  • Microbiota
  • Pancreas / microbiology*
  • Pancreas / physiology
  • Pancreatic Neoplasms / microbiology*
  • Pancreatitis / microbiology*
  • Toll-Like Receptor 2 / immunology
  • Toll-Like Receptor 4 / immunology

Substances

  • Toll-Like Receptor 2
  • Toll-Like Receptor 4